(VIANEWS) - Vulcan Materials Company (VMC), EOG Resources (EOG), Corcept Therapeutics Incorporated (CORT) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Vulcan Materials Company (VMC)
34.5% sales growth and 9.52% return on equity
Vulcan Materials Company and its affiliates produce and supply construction aggregates in America. The company operates in four main segments, Aggregates Asphalt Concrete and Calcium. It offers crushed stones, gravel, sand, or other aggregates. Also, it provides related products and services for the maintenance and construction of roads, highways and other public works. Asphalt Mix offers asphalt mix in Alabama and Arizona as well as in Tennessee and Texas. Ready-mixed concrete is available in California, Maryland and New Jersey as well as New York, Oklahoma and Pennsylvania. It can also be found in Virginia and Washington D.C. Calcium is a segment that mines, makes, and markets calcium products to the water treatment, animal feed and plastic industries. The original name of the company was Virginia Holdco, Inc., but it changed its name into Vulcan Materials Company. Vulcan Materials Company was established in 1909 in Birmingham, Alabama.
Earnings Per Share
As for profitability, Vulcan Materials Company has a trailing twelve months EPS of $4.38.
PE Ratio
Vulcan Materials Company has a trailing twelve months price to earnings ratio of 41.25. Meaning, the purchaser of the share is investing $41.25 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.52%.2. EOG Resources (EOG)
22.7% sales growth and 26.43% return on equity
EOG Resources, Inc., along with its affiliates, searches for, develops, produces, markets, and sells crude oil, natural gas, and natural gaz liquids. The United States' New Mexico and Texas are its principal production areas. Trinidad and Tobago is their Republic. It had 3,747 million oil equivalent net reserves as of December 31, 2021. This includes 1,548 million barrels (MMBbll) of crude oil, condensate, and natural gas liquid reserves, 829 MMBbl, and 8,222 billion cubic yards of natural gas reserve. Formerly known as Enron Oil & Gas Company, the company is now called EOG Resources. EOG Resources Inc. was founded in 1985. It is located in Houston, Texas.
Earnings Per Share
As for profitability, EOG Resources has a trailing twelve months EPS of $-1.04.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.43%.Growth Estimates Quarters
The company's growth estimates for the current quarter and the next is 75% and 33%, respectively.Dividend Yield
Morningstar, Inc. has stated that the next dividend payment will be on October 13, 2022. The forward dividend rate for the year is estimated at 3 and the forward dividend yield to be 2.23%.
Sales Growth
EOG Resources's sales growth for the next quarter is 22.7%.
3. Corcept Therapeutics Incorporated (CORT)
14.1% sales growth and 23.06% return on equity
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with serous ovarian tumors, as well as in Phase III clinical trial for the treatment of solid tumors. The company is also developing selective cortisol modulator combined with Xtandi that is in open label dose finding trial to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
Earnings Per Share
As for profitability, Corcept Therapeutics Incorporated has a trailing twelve months EPS of $0.98.
PE Ratio
Corcept Therapeutics Incorporated has a trailing twelve months price to earnings ratio of 20.72. Meaning, the purchaser of the share is investing $20.72 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.06%.Sales Growth
Corcept Therapeutics Incorporated has experienced a 6.3% and 14.1% sales growth in the most recent quarter.
Yearly Top and Bottom Value
Corcept Therapeutics Incorporated's stock is valued at $20.31 at 15:22 EST, way under its 52-week high of $30.14 and way above its 52-week low of $16.47.
Revenue growth
The year-on-year revenue growth was 5.8%. It now stands at 397.62M in the 12 trailing months.
4. Lear Corporation (LEA)
8.2% sales growth and 4.09% return on equity
Lear Corporation develops and manufactures automotive seating and other electrical distribution systems for original equipment producers in North America and Europe. The company's Seating segment includes leather and fabric products as well as seat covers, recliner mechanism, seat tracks, foams, structures and mechanisms and headrests. It also offers light trucks and compact cars. E-Systems is the company's electrical distribution segment. It routes electrical signals and networks and manages electrical power in vehicles for different powertrains such as hybrid, plug-in hybrid and traditional internal combustion engines. These products include wire harnesses as well as terminals and connectors. They also offer electronic control modules such body control modules and smart junction boxes. Gateway modules and wireless transmitter technology are available. There is also lighting control modules and audio domain controllers. Amplifiers and modules for communication. The company also offers electrification products that consist of charging systems including onboard charging units and cord set charging devices; battery electronics which include battery disconnect units and cell monitoring supervisory system, integrated total batteries control modules; as well as other power management modules such converters and inverter modules. This segment also offers cybersecurity software, advanced vehicle positioning, which allows for autonomous and automated driving; roadside modules, which communicate real-time information to the traffic control system; and cellular protocols that allow vehicle connectivity. It was established in 1917. The headquarters are in Southfield in Michigan.
Earnings Per Share
As for profitability, Lear Corporation has a trailing twelve months EPS of $2.62.
PE Ratio
Lear Corporation has a trailing twelve months price to earnings ratio of 47.05. Meaning, the purchaser of the share is investing $47.05 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.09%.5. SunCoke Energy (SXC)
7% sales growth and 16.28% return on equity
SunCoke Energy, Inc. is an independent coke producer in Brazil and the Americas. It operates in three areas: Domestic Coke and Brazil Coke. Logistics is its core business. The company offers thermal and metallurgical coal. It also offers handling and/or mixed services for steel, coke and electric utility customers. It also owns and manages five cokemaking plants in the United States, and one in Brazil. SunCoke Energy, Inc., was established in 1960. It is located in Lisle, Illinois.
Earnings per Share
SunCoke Energy's trailing twelve-month EPS is $0.18.
PE Ratio
SunCoke Energy's trailing 12 months earnings to price ratio is 48.11. The purchaser of the shares is therefore investing $48.11 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 16.28%.Sales Growth
SunCoke Energy is expecting a 7% increase in sales for its next quarter.
Moving Average
SunCoke Energy's worth is above its 50-day moving average of $8.00 and way higher than its 200-day moving average of $7.57.6. Federal Realty Investment Trust (FRT)
6.9% sales growth and 13.32% return on equity
Federal Realty is an acknowledged leader in the management, ownership, and redevelopment high-quality, retail-based properties. These properties are primarily located in coastal cities from Washington, D.C., Boston, San Francisco, and Los Angeles. Federal Realty was founded in 1962. Its goal is to provide long-term sustainable growth by investing in densely populated and affluent areas where there is more retail demand than supply. Federal Realty's experience includes the creation of mixed-use urban neighborhoods such as Santana Row, San Jose, California; Pike & Rose, North Bethesda (Maryland); and Assembly Row, Somerville, Massachusetts. The unique, vibrant and lively environments, which combine dining, shopping, living, and work, provide an unforgettable experience for their communities. Federal Realty has 104 properties, with approximately 2900 tenants in 24,000,000 square feet and 2,800 housing units. Federal Realty's quarterly dividends have been increasing for 53 years consecutively, which is the longest streak in REIT industry. Federal Realty, a member of the S&P 500 index, is traded on the NYSE as the symbol FRT.
Earnings Per Share
As for profitability, Federal Realty Investment Trust has a trailing twelve months EPS of $4.76.
PE Ratio
Federal Realty Investment Trust has a trailing twelve months price to earnings ratio of 21.5. Meaning, the purchaser of the share is investing $21.5 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.32%.Sales Growth
Federal Realty Investment Trust's sales growth is 8.1% for the current quarter and 6.9% for the next.
Moving Average
Federal Realty Investment Trust is worth less than its 50-day average $103.04, and lower than its 200-day average $106.10.7. Humana (HUM)
6.4% sales growth and 20.72% return on equity
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Earnings per Share
Humana's trailing 12 months earnings per share (EPS) is $28.15.
PE Ratio
Humana's trailing 12 months earnings to price ratio is 17.58. The purchaser of the shares is therefore investing $17.58 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 20.72%.Previous days news about Humana(HUM)
- : rite aid names ex-humana exec elizabeth burr as interim CEO. According to MarketWatch on Monday, 9 January, "Rite Aid Corp. said Monday its board has named Elizabeth Burr, a former Humana Inc. executive, as interim chief executive, replacing Heyward Donigan, who is leaving the role. "